Intravitreal ranibizumab for choroidal neovascularisation in serpiginous choroiditis

Eye

Volumn 23, Issue 9, 2009, Pages 1873-1875

  Song, M H ^a   Roh, Y J ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; CASE REPORT; CHOROIDITIS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INFORMED CONSENT; LETTER; METAMORPHOSIS; OPTICAL COHERENCE TOMOGRAPHY; REPEATED DRUG DOSE; SCAR; SERPIGINOUS CHOROIDITIS; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; TREATMENT DURATION; VISUAL ACUITY;

ADULT; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; CHOROIDITIS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 70349213562     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.346     Document Type: Letter

References (5)

1. Hamilton AM, Bird AC. Geographic choroidopathy. Br J Ophthalmol 1984; 58: 784-797.
2. Lee DK, Suhler EB, Augustin W, Buggage RR. Serpiginous choroidopathy presenting as choroidal neovascularization. Br J Ophthalmol 2003; 87: 1184-1185.
3. Park SP, Ko DA, Chung H, Yu HG. Photodynamic therapy with Verteporfin for juxta foveal choroidal neovascularization in serpiginous choroiditis. Ophthalmic Surg Lasers Imaging 2006; 37: 425-428.
4. Jennifer IL, Christina JF, Laurie LB. Photodynamic therapy for choroidal neovascularization secondary to inflammatory chorioretinal disease. Ann Acad Med Singapore 2006; 35:198-202.
5. Tom SC, Neil MB, Jennifer TF et al. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration. Arch Ophthalmol 2007; 125: 1460-1469. 1879